Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Longevixx
CoreAge Rx and Longevixx both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxLongevixx
Ranked #307 · Grade C
Best for: Difficult to specify, because the site settles almost nothing before you submit a medical history.
Visit LongevixxThe verdict
CoreAge Rx edges out Longevixx on the Rx-Readiness Score, 95 to 31 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Longevixx is still a genuine option — "Plans from $129/mo · confirmed after provider review" is the whole of the pricing: no drug breakdown, no dose breakdown, nothing fixed before an intake. The homepage contradicts itself on coverage within one screen — a ticker reading "50-state telehealth" beside a stat block reading "0 states telehealth access". And the headline result, "~15–20% avg. body-weight change", is sourced to clinical trials of compounded semaglutide and tirzepatide. Those trials do not exist. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Longevixx |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 31/100 · C |
| Overall rank | #1 | #307 |
| Semaglutide | $99/mo | From $129/mo, not confirmed until after provider review |
| Tirzepatide | $149/mo | Not priced separately on the site |
| Coverage | All 50 states | Contradicted on its own homepage — "0 states" beside "50-state telehealth" |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Longevixx
Ranked #307 · Grade C
What we like
- "$0 if you're not approved" is stated plainly and repeatedly
- Separates its programs by molecule and by microdose rather than selling one undifferentiated plan
- Says medication is compounded in the USA and shipped cold-chain, and carries the not-FDA-approved disclosure
The caveats
- The "~15–20% avg. body-weight change" claim is attributed to clinical trials of compounded semaglutide and tirzepatide — no such trials exist; those results belong to studies of the branded drugs
- The only published price is "from $129/mo", confirmed after provider review
- Tirzepatide has its own program page but no price of its own
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Longevixx against other providers on our shortlist.
Or browse the full comparison hub.